Nephrotic Syndrome Industry Anticipated to Expand at 10.5% CAGR During the Forecast Period

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Nephrotic Syndrome Market By 2029?

The nephrotic syndrome market has seen swift expansion in recent years. Its valuation is anticipated to climb from $0.87 billion in 2024 to $0.96 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.7%. This historical expansion can be traced to increasing the incidence of nephrotic syndrome, increasing genetic disorders, rising rates of obesity, increasing use of immunosuppressive medications, and growing impact of genetic factors.

The nephrotic syndrome market is expected to exhibit significant growth over the coming years. It is projected to reach $1.43 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.5%. This expansion during the forecast period is primarily driven by increasing awareness of Nephrotic Syndrome disease, a rise in the prevalence of CKD, the growing occurrence of metabolic disorders, an expanding aging population, and a higher incidence of autoimmune diseases. Notable trends anticipated in the forecast period include the implementation of telemedicine and remote monitoring, the development of innovative drug delivery systems, advancements in treatment modalities, progress in biotechnology, and the seamless integration of digital health technologies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21228&type=smp

What Are The Top Growth Drivers Impacting The Nephrotic Syndrome Market Outlook?

The growing occurrence of kidney ailments is anticipated to drive expansion in the nephrotic syndrome market. Kidney diseases encompass various conditions that hinder the proper functioning of the kidneys, which are vital organs for filtering waste and surplus fluids from the bloodstream. This rise in kidney disease incidence stems from factors like diabetes, high blood pressure, obesity, an aging demographic, and lifestyle modifications such as elevated sodium consumption and insufficient water intake. Nephrotic syndrome exacerbates kidney diseases through damage to the glomeruli, thereby compromising the kidneys’ capacity to filter waste products and retain vital proteins. For example, data from June 2024, provided by the Australian Institute of Health and Welfare, an Australia-based government agency, revealed that the mortality rate due to chronic kidney disease (CKD) in Australia rose from 4.2% in 2021 to 6.2% in 2022. Consequently, the escalating prevalence of kidney disorders is fueling the expansion of the nephrotic syndrome market.

What Are The Emerging Segments Gaining Attention In The Nephrotic Syndrome Market?

The nephrotic syndromemarket covered in this report is segmented –

1) By Type: Drugs; Devices

2) By Diagnosis Tests: Urinalysis; Glomerular Filtration Rate (GFR); Blood Test; Kidney Biopsy; Computerized Tomography (CT) Scan

3) By Application: Clinics; Hospitals; Speciality Centres; Other Applications

Subsegments:

1) By Drugs: Steroids; Immunosuppressants; Diuretics; ACE Inhibitors Or ARBs; Other Drugs

2) By Devices: Dialysis Machines; Peritoneal Dialysis Catheters; Hemodialysis Catheters; Kidney Replacement Therapy Devices

What Are The Major Trends Driving The Growth Of The Nephrotic Syndrome Market?

Major companies in the nephrotic syndrome market are directing their efforts towards creating innovative formulations, such as loop diuretic injections, to improve fluid regulation and reduce edema in patients suffering from nephrotic syndrome. A loop diuretic Injection is defined as an injectable medication that inhibits the reabsorption of sodium and chloride in the loop of Henle, thereby stimulating swift urine production. It is utilized in the management of conditions like acute pulmonary edema, heart failure, and severe hypertension by diminishing excess fluid. As an illustration, in March 2024, Avenacy Inc., a US-based pharmaceutical company, launched furosemide for Injection in the U.S., a generic version of Lasix, which received approval from the Food and Drug Administration for treating edema connected to heart failure, liver cirrhosis, and kidney diseases. Provided in 25-unit packs of 100 mg/10 mL doses, this introduction is a component of Avenacy’s broader strategy to expand its range of injectable medications, with aspirations to launch over 20 products in 2024. This particular drug is prescribed for both adult and pediatric patients for the treatment of edema linked to congestive heart failure, cirrhosis of the liver, and renal disease, encompassing nephrotic syndrome.

Who Are The Major Companies Operating In The Nephrotic Syndrome Market?

Major companies operating in the nephrotic syndrome market are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Amgen Inc., Eli Lilly and Company, Asahi Kasei Corporation, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals, Chugai Pharmaceutical Co. Ltd., Mallinckrodt Company, Evotec SE, Travere Therapeutics Inc., Aurinia Pharmaceuticals Inc., Orbis Biosciences Inc., Alpine Immune Sciences, Kezar Life Sciences, Zenyaku Kogyo Co. Ltd

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/nephrotic-syndrome-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Nephrotic Syndrome Market?

North America was the largest region in the nephrotic syndrome market in 2024. The regions covered in the nephrotic syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Nephrotic Syndrome Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21228&type=smp

Browse Through More Reports Similar to the Global Nephrotic Syndrome Market 2025, By The Business Research Company

Cough Hypersensitivity Syndrome Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cough-hypersensitivity-syndrome-global-market-report

Dumping Syndrome Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dumping-syndrome-global-market-report

Zollinger Ellison Syndrome Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/zollinger-ellison-syndrome-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795